Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The interaction between the host eukaryotic initiation factor 4G (eIF4G) and domain V of the poliovirus internal ribosome entry site (IRES) is a fundamental requirement for the initiation of viral protein synthesis. In the Sabin 2 vaccine strain, a specific G-to-A point mutation at nucleotide 481 (G481A) within domain V significantly reduces the binding affinity of eIF4G, which is the primary mechanism for the strain's attenuated neurovirulence (Ochs et al., 2003; JBC, 2018). This interaction is essential for recruiting the 40S ribosomal subunit to the viral RNA, bypassing the need for a 5' cap (Sweeney et al., 2014). Because this interface is critical for viral replication but distinct from the mechanisms used for most host cell mRNAs, it represents a potential target for the development of specific antiviral agents. Small molecules like 4EGI-1 and hippuristanol have been used in research to study and inhibit this translational pathway, highlighting the therapeutic potential of disrupting the eIF4G-IRES complex (Cell, 2006; JBC, 2018).
Inhibition of viral translation initiation by disrupting the recruitment of the 40S ribosomal subunit to the viral IRES.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host translation initiation factor eIF4G binding to Sabin 2 poliovirus IRES domain V (eIF4G-Sabin 2 IRES dV interaction).